Gold standard for question 5133b9455274a5fb0700000c:[[aataaa], [aauaaa]]
Hypothesis for question 5133b9455274a5fb0700000c:[[transcription], [type], [promoter], [ubiquitin-conjugating enzyme, ube2d2 protein, human], [mutation], [histone, h2afx protein, human], [activity], [l1], [formation], [cell], [ccaat], [protein kinase ck2], [observation], [ta], [caspase recognition motifs], [endonuclease, dna excision repair protein ercc-5], [l1 endonuclease], [flank], [variant], [hexanucleotide], [pyrimidine, zaleplon, voriconazole, oxyphencyclimine, imatinib, piritrexim, pazopanib, udenafil, alniditan, dasatinib, n-(2-aminophenyl)-4-((4-pyridin-3-ylpyrimidin-2-ylamino)methyl)benzamide, pki 166, bafetinib, 4-((3-chloro-4-methoxybenzyl)amino)-2-(2-(hydroxymethyl)-1-pyrrolidinyl)-n-(2-pyrimidinylmethyl)-5-pyrimidinecarboxamide, mp470, pirinixic acid, rosuvastatin, pyrimidine], [nt], [box], [ck2], [auuaaa], [stretch], [factor], [class], [enzyme], [stemloop], [residue], [cdna], [phosphorylation], [kinase], [caspase], [tail], [tatabox], [attachment], [aauaaa], [exon], [cleavage], [enhancer], [transcript], [insertion], [duplication], [protein, agr2 protein, human, wfdc1 protein, human, frizzled related protein-1, lgi1 protein, human, t-cell leukemia translocation-associated protein, human, nbl1 protein, human], [analysis], [bp, blood pressure], [recognition], [base], [element], [motif], [target], [splice], [region], [gene, genes and gene therapy]]
Gold standard for question 513f45abbee46bd34c000013:[[adipose tissue], [fibrotic tissue]]
Hypothesis for question 513f45abbee46bd34c000013:[[nodule], [preparation], [radioligand], [vessel], [thymidine], [factor1], [amplification], [role], [chicken thyrotropin receptor], [haemorragica], [heterodimer], [culture], [blot], [incorporation], [fulllength], [corpus], [insulin-like growth factor-1 receptor], [test], [tsh receptor], [tsh], [camp], [lack], [effect], [chicken], [remodel], [production], [hormone, hormones], [igf-1r], [pcr], [splice], [increase], [analogy], [growth], [orbital], [tshra], [tshrc], [correlation], [distribution], [transcript], [share], [destruction], [observation], [g2 s], [depot], [wherea], [albicantium], [marker], [name], [tsh], [patient], [immunostain], [tsh-r], [assay], [exon], [protein, agr2 protein, human, wfdc1 protein, human, frizzled related protein-1, lgi1 protein, human, t-cell leukemia translocation-associated protein, human, nbl1 protein, human], [antigen, chondroitin sulfate proteoglycan 4], [eye], [reaction], [evidence], [level], [author], [fibroblast], [cell], [datum], [reactivity], [serum], [antibody, hepatitis b hyperimmune globulin, imc1c11, cytomegalovirus-specific hyperimmune globulin, rfb4(dsfv)-pe38 recombinant immunotoxin], [disorder], [g2], [link], [thyrotropin receptor, thyroid stimulating hormone receptor, thyroid-stimulating hormone receptor], [associate], [muscle], [disease]]
Gold standard for question 51477de5d24251bc05000020:[[parathyroid gland], [pancreatic diseases, moderate pancreatic duct dysplasia, pancreas, disorder pancreas, mucoviscidosis, pancreatic disorder, severe pancreatic duct dysplasia, pancreatic duct dysplasia, disorder of pancreas], [pituitary gland]]
Hypothesis for question 51477de5d24251bc05000020:[[neoplasia, pharynx neoplasm malignant, neoplasia renal, malignancy, polyps nasal, neuroblastoma, renal neoplasia, cancer--living with cancer, nasal polyp, alternative therapy for cancer, chemotherapy, cancer and pregnancy, oncology, lipoma, hyperplasia, phaeochromocytoma, teratoma, cancer alternative therapies, polyps, tumors, benign, pheochromocytoma, neoplasm (nos), living with cancer, benign tumors, tumor, cancer chemotherapy, neoplasm adrenal, neoplasm nos, cancer, hypernephroma, pituitary neoplasm benign, neoplasms], [neurofibromatosis, schwannomatosis, neurofibromatosis, neurofibromin 1, neurofibromatosis syndrome], [von hippel lindau], [ret, rearranged during transfection protooncogene, ret proto-oncogene], [lindau], [impact], [history], [recurrence], [inheritor], [propensity], [men type 1, multiple endocrine neoplasia, type i], [example], [hippel], [product], [picture], [2a], [2b], [regard], [investigation], [men-1], [thyroid, generalized thyroid hormone resistance, disorder thyroid, thyroid diseases, thyroid cyst, disorder of thyroid gland, thyroid hormone resistance syndrome], [hyperfunction], [von], [menin, men1 gene], [feature], [hyperplasium], [man], [time], [suppressor], [family, family issues], [hyperparathyroidism, hyperparathyroidism], [men1, multiple endocrine neoplasia, type i, men1 gene], [tumour, pharynx neoplasm malignant, neoplasia renal, malignancy, polyps nasal, renal neoplasia, neuroblastoma, cancer--living with cancer, alternative therapy for cancer, cancer and pregnancy, chemotherapy, nasal polyp, oncology, lipoma, hyperplasia, phaeochromocytoma, teratoma, cancer alternative therapies, polyps, tumors, benign, pheochromocytoma, neoplasm (nos), living with cancer, benign tumors, tumor, cancer chemotherapy, neoplasm adrenal, neoplasm nos, cancer, hypernephroma, neoplasms, pituitary neoplasm benign], [carcinoma, cancer (nos), wilms tumor, renal carcinoma, secretory breast carcinoma, ovarian cyst malignant, adenocarcinoma, carcinoma transitional cell, carcinoma kidney, brain neoplasm malignant, neoplasm malignant, carcinoma, kidney carcinoma, testis neoplasm malignant, adenocarcinoma nos, cancer, seminoma, vaginal neoplasm malignant, pancreatic carcinoma, familial], [cause], [gene, genes and gene therapy], [patient], [mutation]]
Gold standard for question 5149199dd24251bc05000040:[[neostigmine], [pyridostigmine]]
Hypothesis for question 5149199dd24251bc05000040:[[objective], [sevenmonth], [c547], [randomize], [antibody, hepatitis b hyperimmune globulin, imc1c11, cytomegalovirus-specific hyperimmune globulin, rfb4(dsfv)-pe38 recombinant immunotoxin], [gene, genes and gene therapy], [achei], [mutation], [motor], [mtm1], [syndrome], [course], [deficit, undernourished, malnutrition, nutritional deficiency, deficiency state], [observation], [reversal], [randomise], [series], [regard], [mtm1], [drug, medicines], [transmission], [blockade], [keyword], [neuritis, neuritis motor, neuropathy peripheral, neuritis peripheral], [ache], [datum], [quasirandomise], [acetylcholinesterase], [describedi], [pathophysiology, arm injuries and disorders], [structure], [cms gene mutation], [xlmtm], [block], [result], [fatigability], [strength], [trial, clinical trials], [presentation], [mg, myasthenia gravis, magnesium], [finding], [article], [option], [control], [efficacy], [form], [outcome], [cm], [junction], [agent], [sevoflurane], [weakness, tiredness, weakness generalized, fatigue, weariness, strength loss of, lassitude, prostration], [function], [disease], [response], [study, clinical trials]]
Gold standard for question 515bd543298dcd4e51000001:[[fibroblast growth factor receptor 1, h2], [fibroblast growth factor receptor 1, h3]]
Hypothesis for question 515bd543298dcd4e51000001:[[type], [majority], [model], [alus], [analysis], [centrifugation], [element1], [event], [expression], [suggestion], [nuclear element-1 ( line-1 ) elements], [breakpoint], [genome], [site], [homology], [leave], [bias], [microsatellite], [insertion], [credence], [substitution], [subfamily], [expectation], [mutability], [acceptor], [target], [intron], [location], [family, family issues], [loss], [context], [minisatellite], [size], [alu sequences], [alu element], [composition], [map, mapre1 protein, human, trip10 protein, human, xrn1 protein, human, tacc1 protein, human], [nucleotide], [particularly alu elements], [polymorphism], [taa, thoracic aortic aneurysm, thoracic aortic aneurysm without rupture, aneurysm of thoracic aorta], [lhgrs], [retroposition], [g+ c], [repeat], [class], [conversion], [advantage], [pair], [base], [housekeep], [dna], [proportion], [range], [phenomenon], [lhgr], [frequency], [effect], [boundary], [line], [gc, group-specific component, group-specific component (vitamin d binding protein)], [evolution], [structure], [alu elements], [distribution], [result], [feature], [density], [gcpoor], [alu], [region], [sequence]]
Gold standard for question 515bf6d6298dcd4e51000004:[[skin cancer], [adi prostate cancer], [gastric adenocarcinoma], [colon adenocarcinoma], [colitis-associated cancer (cac)], [breast cancer, carcinoma breast], [hodgkin lymphoma, hodgkin disease], [nasopharyngeal carcinoma], [t-cell neoplasia]]
Hypothesis for question 515bf6d6298dcd4e51000004:[[transcription], [piwil2], [complex], [protein, agr2 protein, human, wfdc1 protein, human, frizzled related protein-1, lgi1 protein, human, t-cell leukemia translocation-associated protein, human, nbl1 protein, human], [immunoprecipitation], [estimate], [cdc45 -mcm-gins ) complex], [analysis], [molecule], [activator], [drive], [cmg], [study, clinical trials], [mobility], [range], [formation], [serine / threonine kinase], [metallopeptidase], [metastasis], [l91p], [proliferation], [reporter], [kill], [transformation], [sample], [report], [usa], [transducer], [carcinogenesis], [signal], [development], [triton], [wherea], [rna, telomerase rna, rna, mitochondrial], [fusion], [piwil2], [datum], [initiation], [specimen], [l71p], [lubrol], [wx], [mmps], [increase], [a95t], [strategy], [breast], [tpl2 kinase], [experiment], [block], [profile], [mcm27], [activity], [skin], [ability], [cdc45, cell division cycle 45, s. cerevisiae, homolog-like], [frequency], [level], [transfer], [activation], [mcm2, minichromosome maintenance complex component 2, minichromosome maintenance, s. cerevisiae, homolog of, 2], [line], [gin], [stat3, signal transducer and activator of transcription 3 (acute-phase response factor), signal transducer and activator of transcription 3], [cdc45, cell division cycle 45, s. cerevisiae, homolog-like], [promotion], [overexpression], [progression], [stat3, signal transducer and activator of transcription 3 (acute-phase response factor), signal transducer and activator of transcription 3], [role], [tumor, pharynx neoplasm malignant, neoplasia renal, malignancy, polyps nasal, neuroblastoma, renal neoplasia, cancer--living with cancer, chemotherapy, nasal polyp, alternative therapy for cancer, cancer and pregnancy, oncology, lipoma, hyperplasia, phaeochromocytoma, teratoma, cancer alternative therapies, polyps, tumors, benign, pheochromocytoma, neoplasm (nos), living with cancer, benign tumors, tumor, cancer chemotherapy, neoplasm nos, neoplasm adrenal, cancer, hypernephroma, neoplasms, pituitary neoplasm benign], [keratinocyte], [suppression], [tpl2, mitogen-activated protein kinase kinase kinase 8], [kinase], [growth], [expression], [tpl2, mitogen-activated protein kinase kinase kinase 8], [prostate, disorder of prostate, prostatic pain, prostate diseases], [adus]]
Gold standard for question 515ffc2b298dcd4e51000035:[[aspergillus terreus], [aspergillus niger], [ustilago maydis]]
Hypothesis for question 515ffc2b298dcd4e51000035:[[cluster], [01], [transcription], [ion], [identification], [method], [chemical], [fermentation], [flask], [bacterium], [facilitator], [product], [reaction], [cultivation], [saltassist], [regard], [transporter], [shake, tremor, shaking], [maydi], [promise], [substrate], [level], [organelle], [superfamily], [pretreat], [metabolism], [fe, general transcription factor iie, polypeptide 2, general transcription factor iie, polypeptide 1, alpha 56kda, general transcription factor iie, polypeptide 1, general transcription factor iie, polypeptide 2, beta 34kda], [candidate], [array], [decarboxylase], [inhibition], [compound], [target], [subvermispora], [application], [clone], [seawater], [analysis], [transcriptome], [glucose, acid citrate dextrose, citrate phosphate dextrose], [biomass], [potential], [condition], [fenton], [productivity], [enzyme], [concentration], [pretreatment], [cell], [terreus], [nitrogen], [growth], [base], [cellulose, k-y jelly], [limitation], [fungus, molds]]
Gold standard for question 5160412d298dcd4e5100003c:[[h4k20 monomethylation], [h3k4 monomethylation]]
Hypothesis for question 5160412d298dcd4e5100003c:[[set7, set domain containing (lysine methyltransferase) 7, set domain-containing protein 7], [bind], [recruitment], [dna], [p65, v-rel avian reticuloendotheliosis viral oncogene homolog a, v-rel reticuloendotheliosis viral oncogene homolog a (avian)], [kinase], [histone methyltransferase set7], [dnmt1, dna methyltransferase 1, dna (cytosine-5-)-methyltransferase 1], [study, clinical trials], [fate], [msk1, ribosomal protein s6 kinase, 90kda, polypeptide 5, ribosomal protein s6 kinase, 90-kd, 5], [h4k20], [variety], [mechanism], [coactivator], [lys27], [setdb1, set domain protein, bifurcated, 1, set domain, bifurcated 1], [b p65 gene], [h19, h19 gene, h19, imprinted maternally expressed transcript (non-protein coding)], [discovery], [glioma, glioma], [ezh2, enhancer of zeste, drosophila, homolog 2, enhancer of zeste homolog 2 (drosophila)], [language], [influence], [h19, h19 gene, h19, imprinted maternally expressed transcript (non-protein coding)], [h3k4 m3], [dnmt3b], [me3], [trimethylation], [development], [histone h4 lysine 20], [effect], [enhancerofzeste], [histone 3], [imprint], [histone h3s10], [h4, coiled-coil domain containing 6, fibroblast growth factor receptor 1, coiled-coil domain-containing protein 6], [hematopoiesis], [setdb1, set domain protein, bifurcated, 1, set domain, bifurcated 1], [factor], [suz12, suppressor of zeste 12 homolog (drosophila), suppressor of zeste 12, drosophila, homolog of], [h3k4m3], [dnmt3b], [control], [stress-activated protein kinase 1], [suz12, suppressor of zeste 12 homolog (drosophila), suppressor of zeste 12, drosophila, homolog of], [response], [stressactivate], [stem], [ezh2, enhancer of zeste, drosophila, homolog 2, enhancer of zeste homolog 2 (drosophila)], [h1 linker histone], [mitogen], [set7, set domain containing (lysine methyltransferase) 7, set domain-containing protein 7], [dnmt1, dna methyltransferase 1, dna (cytosine-5-)-methyltransferase 1], [protein, agr2 protein, human, wfdc1 protein, human, frizzled related protein-1, lgi1 protein, human, t-cell leukemia translocation-associated protein, human, nbl1 protein, human], [phosphorylation], [biology], [histone lysine methyltransferases], [role], [activity], [polymerase], [diversity], [h3k4], [linker], [domaincontain], [elongation], [methylwrit], [rna, telomerase rna, rna, mitochondrial], [disruption], [repression], [region], [code], [production], [initiation], [trimethylate], [h1, chloride intracellular channel 4], [histone h3 lysine 4], [receptor], [prc2], [h3s10], [rna polymerase ii], [complex], [monomethylation], [estrogen], [prc2], [h3k4 m1], [h1, chloride intracellular channel 4], [enzyme], [histone methyltransferase], [regulation], [function], [polycomb], [bim promoter], [h3k4m1], [bim, bcl2-like 11 (apoptosis facilitator), bcl2-like 11], [promoter], [gene, genes and gene therapy], [histone h3], [h3k27me3], [transcription], [h3k27 me3], [cell], [h3, fibroblast growth factor receptor 1], [methylation], [lysine, biocytin], [modification]]
